Treatment of mycosis fungoides: Overview

Journal of Cutaneous Medicine and Surgery

Volumn 10, Issue 5, 2006, Pages 228-233

  Freiman, Anatoli ^a   Sasseville, Denis ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; BEXAROTENE; CARMUSTINE; CHLORMETHINE; CORTICOSTEROID; DENILEUKIN DIFTITOX; ETRETIN; GEMCITABINE; IMIQUIMOD; METHOTREXATE; MONOCLONAL ANTIBODY; PENTOSTATIN;

ALOPECIA; ANHIDROSIS; ARTICLE; BONE MARROW TRANSPLANTATION; BULLOUS SKIN DISEASE; CANCER RADIOTHERAPY; CONTACT ALLERGY; CREAM; CYTOPENIA; DEPRESSION; DESQUAMATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ELECTRON THERAPY; ERYTHEMA; FLU LIKE SYNDROME; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERPIGMENTATION; HYPERTHYROIDISM; LEUKOPENIA; MYCOSIS FUNGOIDES; PHOTOTHERAPY; PRIORITY JOURNAL; PUVA; SKIN IRRITATION; STEM CELL TRANSPLANTATION; T CELL LYMPHOMA; TELANGIECTASIA; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; URTICARIA; XEROSIS; MULTIMODALITY CANCER THERAPY; REVIEW; SKIN TUMOR;

COMBINED MODALITY THERAPY; HUMANS; MYCOSIS FUNGOIDES; SKIN NEOPLASMS;

EID: 34047189387     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2006.00051     Document Type: Article

References (37)

1. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood, Feb 3 2005. [Epub ahead of print].
2. Barankin B, Freiman A. Misnomers in dermatology. J Cutan Med Surg 2005;9:284-8.
3. Girardi M, Heald PW, Wilson LD. The pathogenesis of mycosis fungoides. N Engl J Med 2004;350:1978-88.
4. Zackheim HS. Treatment of patch-stage mycosis fungoides with topical corticosteroids. Dermatol Ther 2003;16:283-7.
5. Zackheim HS, Kashani-Sabet M, Amin S. Topical corticosteroids for mycosis fungoides. Experience in 79 patients. Arch Dermatol 1998;134:949-54.
6. Kim YH. Management with topical nitrogen mustard in mycosis fungoides. Dermatol Ther 2003;16:288-98.
7. Kim YH, Martinez G, Varghese A, Hoppe RT. Topical nitrogen mustard in the management of mycosis fungoides: update of the Stanford experience. Arch Dermatol 2003;139:165-73.
8. Lee LA, Fritz KA, Golitz L, et al. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard. J Am Acad Dermatol 1982;7:590-8.
9. Zackheim HS. Topical carmustine (BCNU) in the treatment of mycosis fungoides. Dermatol Ther 2003;16:299-302.
10. Liu HL, Kim YH. Bexarotene gel: a Food and Drug Administration-approved skin-directed therapy for early-stage cutaneous T-cell lymphoma. Arch Dermatol 2002;138:398-9.
11. Breneman D, Duvic M, Kuzel T, et al. Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma. Arch Dermatol 2002;138:325-32.
12. Deeths MJ, Chapman JT, Dellavalle RP, et al. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream. J Am Acad Dermatol 2005;52:275-80.
13. Hoppe RT. Mycosis fungoides: radiation therapy. Dermatol Ther 2003;16:347-54.
14. Jones GW, Kacinski BM, Wilson LD, et al. Total skin electron radiation in the management of mycosis fungoides: consensus of the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Project Group. J Am Acad Dermatol 2002;47:364-70.
15. Rampino M, Ragona R, Monetti U, et al. Total skin electron beam therapy in mycosis fungoides. Our experience from 1985 to 1999. Radiol Med (Torino) 2002;103:108-14.
16. Ysebaert L, Truc G, Dalac S, et al. Ultimate results of radiation therapy for T1-T2 mycosis fungoides (including reirradiation). Int J Radiat Oncol Biol Phys 2004;58:1128-34.
17. Baron ED, Stevens SR. Phototherapy for cutaneous T-cell lymphoma. Dermatol Ther 2003;16:303-10.
18. Querfeld C, Rosen ST, Kuzel TM, et al. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy. Arch Dermatol 2005;141:305-11.
19. Ghodsi SZ, Hallaji Z, Balighi K, et al. Narrow-band UVB in the treatment of early stage mycosis fungoides: report of 16 patients. Clin Exp Dermatol 2005;30:376-8.
20. Nistico S, Costanzo A, Saraceno R, Chimenti S. Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides. Br J Dermatol 2004;151:877-9.
21. Zic JA. The treatment of cutaneous T-cell lymphoma with photopheresis. Dermatol Ther 2003;16:337-46.
22. Wilson LD, Jones GW, Kim D, et al. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides. J Am Acad Dermatol 2000;43(1 Pt 1):54-60.
23. Vonderheid EC. Photopheresis: current and future perspectives. J Cutan Med Surg 2003;(4 Suppl):1-24.
24. Kuzel TM, Roenigk HH Jr, Samuelson E, et al. Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sezary syndrome. J Clin Oncol 1995;13: 257-63.
25. Huber MA, Kunzi-Rapp K, Staib G, Scharffetter-Kochanek K. Management of refractory early-stage cutaneous T-cell lymphoma (mycosis fungoides) with a combination of oral bexarotene and psoralen plus ultraviolet bath therapy. J Am Acad Dermatol 2004; 50:475-6.
26. Singh F, Lebwohl MG. Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: a case series. J Am Acad Dermatol 2004;51:570-3.
27. Talpur R, Apisarnthanarax N, Ward S, Duvic M. Treatment of refractory peripheral T-cell lymphoma with denileukin diftitox (Ontak). Leuk Lymphoma 2002;43:121-6.
28. Olsen E, Duvic M, Frankel A, et al. Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. J Clin Oncol 2001;19:376-88.
29. Rook AH, Kuzel TM, Olsen EA. Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2. Hematol Oncol Clin North Am 2003;17:1435-48, ix.
30. Lundin J, Hagberg H, Repp R, et al. Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome. Blood 2003;101:4267-72.
31. Knox S, Hoppe RT, Maloney D, et al. Treatment of cutaneous T-cell lymphoma with chimeric anti-CD4 monoclonal antibody. Blood 1996;87:893-9.
32. Kuzel TM. Systemic chemotherapy for the treatment of mycosis fungoides and Sezary syndrome. Dermatol Ther 2003;16:355-61.
33. Zackheim HS, Kashani-Sabet M, McMillan A. Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients. J Am Acad Dermatol 2003;49:873-8.
34. Zinzani PL, Baliva G, Magagnoli M, et al. Gemcitabine treatment in pretreated cutaneous T-cell lymphoma: experience in 44 patients. J Clin Oncol 2000;18:2603-6.
35. Soligo D, Ibatici A, Berti E, et al. Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimen. Bone Marrow Transplant 2003;31:663-6.
36. Kelly WK, Richon VM, O'Connor O, et al. Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously. Clin Cancer Res 2003;9(10 Pt 1):3578-88.
37. Wysocka M, Benoit BM, Newton S, et al. Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15. Blood 2004;104:4142-9.